More Stories

More Stories

July 23, 2018

The ASCO Daily News spoke recently with Edward S. Kim, MD, of the Carolinas Healthcare System Levine Cancer Institute, about key data presented during the 2018 ASCO Annual Meeting regarding drug activity across tumor types.

Read more
July 23, 2018

As mortality rates for breast cancer have improved in high-income countries over the last several decades, there is increasing focus on patient quality of life and avoiding long-term morbidities.

Read more
June 2, 2018

For decades, insurance plans have used limited provider and hospital networks as a strategy to contain costs and lower insurance premiums.

Read more

June 3, 2018

The majority of patients with cancer will require opioid therapy for acute or chronic pain at some point.

Read more

June 3, 2018

Can some patients with cancer benefit from more aggressive treatment than standard regimens?

Read more

June 3, 2018

Combining pembrolizumab with conventional chemotherapy in the first-line setting significantly prolongs median overall survival (OS) in patients with metastatic squamous non–small cell lung cancer (NSCLC)

Read more

June 3, 2018

Since the enactment of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), ASCO has been engaged in helping members to prepare and succeed under this new reimbursement mechanism.

Read more

June 3, 2018

Lung cancer is the most common cause of cancer-related death worldwide.Lung cancer is the most common cause of cancer-related death worldwide.

Read more

June 3, 2018

Cancer incidence is increasing worldwide, and this is especially problematic in low-resource countries where cancer is diagnosed at more advanced stages.

Read more
June 3, 2018

Monday InBriefs: Highlights from ASCO18

Read more

June 3, 2018

Ana M. Molina, MD, specializes in genitourinary medical oncology at Weill Cornell Medicine and New York-Presbyterian Hospital and is a long-time ASCO Annual Meeting attendee.

Read more

June 3, 2018

On June 4, Gregory H. Reaman, MD, FASCO, professor of pediatrics at George Washington University School of Medicine and Health Sciences, will receive the Pediatric Oncology Award for his outstanding leadership and achievements in the field.

Read more

June 3, 2018

ASCO’s Partners in Progress Award, to be presented June 4, honors an individual whose patient advocacy has impacted public awareness about cancer or resulted in additional support—either legislatively or fiscally—for cancer research, treatment, prevention, or care.

Read more

June 3, 2018

John Mendelsohn, MD, is internationally renowned for his contributions to basic science and clinical trials that helped explicate the role of EGFRs on cancer cell proliferation.

Read more

June 3, 2018

The field of cancer immunotherapy has greatly advanced during the last 7 years.

Read more

June 3, 2018

Muhammad Beg, MD, of the University of Texas Southwestern Medical Center, is a seasoned ASCO Annual Meeting attendee and current member of ASCO’s Cancer Communications Committee.

Read more

June 2, 2018

Patients with relapsed or refractory multiple myeloma treated with once-weekly carfilzomib had a higher response rate than patients treated with the twice-weekly regimen in the ARROW study, introducing the potential for more convenient dosing for patients.

Read more

June 3, 2018

Analyzing cell-free DNA (cfDNA) circulating in plasma or serum can help oncologists determine the genotype of tumors noninvasively to guide treatment decisions and may eventually allow them to monitor treatment response, predict recurrence, and screen for cancer.

Read more

June 3, 2018

Last week, the National Cancer Institute (NCI) of the National Institutes of Health (NIH) released its 2018 Annual Report to the Nation on the Status of Cancer.

Read more

June 3, 2018

Ralph R. Weichselbaum, MD, accepted the 2018 David A. Karnofsky Memorial Award and Lecture June 2 for his contributions to the field of radiation oncology.

Read more